Search Results
Tau-targeted therapy landscape in Alzheimer’s disease
Expanding the Target Landscape in Alzheimer's Disease through Open Science - 21 September 2021
Tau PET imaging: the current landscape
A Revolution in the Treatment Landscape of Alzheimer's Disease
The impact of RGn530 in the treatment landscape of Alzheimer's disease
The future of diagnostics in the evolving Alzheimer’s disease care landscape
Data-driven approaches improve Tau-PET biomarkers in Alzheimer's disease
Expert Roundtables: Alzheimer's treatment—Beyond plaques and tangles
Why is Alzheimer’s disease so difficult to treat? - Krishna Sudhir
The promise of 4R tau-PET tracer development
Jeffrey Cummings discusses Drug Development & the Changing Alzheimer's Disease Therapeutic Landscape
Syndrome-biomarker correlations in Alzheimer disease: Insights from ADNI and tau PET